UCB Transplant with Myeloablative Prep
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
What will happen during the trial?
This is a study to collect routine clinical data from UCBT using unrelated single or double UCB units as an alternative, non-HLA-matched stem cell source for patients with hematological diseases.
- data collection from transplant preparative therapy consisting of treatments with chemotherapeutic regimens and total body irradiation.
- data collection from umbilical cord blood selection and infusion.
- data collection from standard supportive disease and transplant related care.
Pre- and post-transplant medication, UCB selection and infusion, supportive care, and follow-up will be according to the current University of Minnesota BMT guidelines.
An average of 18 patients are expected to be treated on this protocol per year.
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 200 patients (estimated)
- Sponsors
- University of Minnesota - Masonic Cancer Center
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, Cord Blood, Radiation Therapy
- Trial Type
- Supportive
- Last Update
- 2 weeks ago
- SparkCures ID
- 386
- NCT Identifier
- NCT01962636
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.